ARCHIVES

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

November 4, 1994

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999